The absolute increase in the incidence of lung cancer in the major industrialized countries of the world and the disappointing results of treatment are attracting increasing attention of clinicians. Over the past 20 years, lung cancer has firmly taken a leading position in the structure of cancer morbidity. Statistics of lung cancer are characterized by obvious negative features: a steady and rapid rate of increase in morbidity and mortality, low figures of five-year survival of patients. Along with the increase in morbidity there was an increase in the mortality rate in cancer of this localization. The main causes of high mortality in patients with lung cancer are the belated diagnosis and low efficiency of existing methods of treatment, according to the Internet publication for girls and women from 14 to 35 years old Pannochka. net With the prevalence of the T1N0M0 process, surgical treatment provides a five-year survival rate in 80-90% of patients. When patients with stage III of the process are identified, the effectiveness of this type of treatment is reduced by a factor of 10, and at stage IV the chances of recovery are zero.

While the techniques for removing all or part of the lung in cancer have been carefully developed, the issues of timely diagnosis and evaluation of the prevalence of the process represent significant difficulties. These difficulties, first of all, are due to the variety of clinical manifestations of this disease, which depends not only on the location and type of growth, but also on the features of metastasis. An inaccurate estimate of the prevalence of the tumor makes it impossible to conduct targeted treatment: surgical, radiation or chemotherapy and entails often unjustified trial thoracotomy.

health. sumy. ua.

Keywords:.